Allergic contact dermatitis to Toxicodendron radicans (poison ivy) is mediated by the hapten urushiol. An urushiol-specific, interleukin 2 (IL-2)-dependent T cell clone (RLB9-7) was generated from the peripheral blood of a patient with a history of allergic contact dermatitis to T. radicans. This clone proliferated specifically to both leaf extract and pure urushiol. Although the clone had the phenotype CD3+CD4+CD8', proliferation to antigen was blocked by anti-CD8 and anti-HLA-A, B, C but not by anti-CD4, suggesting that CD4 was not functionally associated with the T cell receptor. Furthermore, studies with antigen-presenting cells from MHC-typed donors indicated that the clone was MHC class 1 restricted. RLB9-7 was WT31 positive, indicating it bears the afi T cell receptor. The clone lacked significant natural killer cell activity and produced only low levels of IL-2 or y-interferon upon antigen stimulation. Addition of RLB9-7 to autologous peripheral blood mononuclear cells in the presence of urushiol inhibited the pokeweed mitogen-driven IgG synthesis. This suppression was resistant to irradiation (2,000 rad) and was not seen when RLB9-7 was added to allogeneic cells, even in the presence of irradiated autologous antigen-presenting cells, suggesting that suppression was MHC restricted and not mediated by nonspecific soluble factors. However, RLB9-7 cells in the presence of urushiol inhibited the synthesis of tetanus toxoid-specific IgG by autologous lymphocytes, indicating that the suppression, although triggered specifically by urushiol, was nonspecific.
Introduction
Allergic contact dermatitis to Toxicodendron radicans (rhus or poison ivy) has been shown to be a delayed hypersensitivity response to urushiol, a catechol with a C 15 lipophilic tail (1, 2) . Previous studies (3) have demonstrated that lymphocytes from patients with a recent history of allergic contact dermatitis to Toxicodendron radicans will proliferate in vitro to urushiolcoupled erythrocytes. This report describes the generation from peripheral blood of a urushiol-specific T cell clone with immunoregulatory properties.
T cell clones specific for nickel sulfate and cobalt chloride have been cloned from the peripheral blood (4, 5) and skin lesions (6) of sensitive patients. These clones, which were CD4+, proliferated and produced both interleukin 2 (IL-2) and -y-interferon in response to antigen. It was hypothesized that these cells may be mediators of the delayed hypersensitivity response. There are additional literature reports describing the generation of T cell lines and clones from a large variety of human pathological lesions including autoimmune thyroiditis (7) , plaques of multiple sclerosis (8) , tumors (9) , and kidney allografts undergoing rejection (10) . Unfortunately, most of these studies are handicapped by the lack of a known relevant antigen. Exceptions include the cloning of lepromin-triggered CD8+ suppressor cells from lesions oflepromatous leprosy (11, 12 ) the cloning of hepatitis B virus-specific clones from livers exhibiting chronic active hepatitis B (13) , and suppressor cells from peripheral blood of patients with acute EBV infectious mononucleosis (14) .
This article reports on the generation of a urushiol-specific T cell clone from a donor with a history of allergic contact dermatitis to T. radicans. This clone proliferated specifically both to pure urushiol and to leaf extract. Addition of these cells to a pokeweed mitogen (PWM)-induced IgG synthesis system with autologous lymphocytes was found to suppress IgG production in the presence of urushiol but not in its absence. The properties of this urushiol-triggered nonspecific suppressor clone were further investigated and its potential role in downregulating delayed contact hypersensitivity is discussed.
Methods
Preparation ofperipheral blood mononuclear cells (PBMC). Heparinized peripheral venous blood was separated into PBMC by centrifugation on Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) gradients, followed by washing. Sheep red blood cell receptor-positive (E+)' T cells and receptor-negative (E-) non-T cells were isolated by rosetting followed by centrifugation over a Ficoll-Hypaque gradient and lysis of sheep red blood cells (SRBC) by ammonium chloride as described (15) .
Production of IL-2-containing conditioned medium. Crude IL-2 preparations were generated by treatment of PBMC isolated from buffy coat from platelet donations with 4 yg/ml phytohemagglutinin (Burroughs Wellcome, Research Triangle Park, NC) and (5 ng/ml) TPA (Sigma Chemical Co., St. Louis, MO) for 4 h at 370C (1 X 106 cells/ml). The cells were then washed four times and resuspended (1 X biological Associates, Bethesda, MD). The cells were cultured 72 h in 250-cm2 flasks (Corning Glass Works, Corning, NY), and the conditioned medium was harvested by centrifugation. Preparations were tested for their ability to maximally support the growth of IL-2-dependent human cell lines at a 10% final concentration of conditioned medium.
Generation ofurushiol-specific Tcell lines. PBMC from a urushiolsensitive donor, 11 months post rhus dermatitis, were sensitized in vitro against rhus extract (1:800) for 7 d in 10% human AB sera (Pel Freeze Biologicals, Rogers, AZ) supplemented RPMI 1640 medium containing 4 mM glutamine, 25 mM Hepes, gentamycin, and 0.5% sodium bicarbonate. The line was then carried in IL-2 media consisting of RPMI 1640 containing 10% FCS, 10% IL-2-containing conditioned medium (-3 U/ml final concentration), 4 mM glutamine, and 5 Ag/ml gentamycin. After Rhus extract (in DMSO) was used at a (1:800) final dilution. Pure urushiol, however, was added to proliferation assays in the form of urushiol-treated cell debris at a (1:10) dilution as described below, along with 5000 rad irradiated PBMC (2 X 105/ml) as a source of antigen-presenting cells.
Treatment ofPBMC with urushiol. Urushiol was added to proliferation and IgG production assays in the form of treated PBMC. Ten million irradiated (5000 rad) PBMC were resuspended in 0.2 ml of either DMSO, or a DMSO solution of pure urushiol at 0.08 mg/ml.
The cells were incubated at 370C for 30 min and washed three times (centrifugation 2,000 rpm for 10 min). The nonviable cell debris was then resuspended in 1.0 ml of supplemented RPMI 1640 medium for addition to proliferation or IgG production assays at a (1:10) final dilution.
Cytotoxicity assay. Cultured T cells were tested for cytotoxicity against the natural killer cell (NK) target K562 as well as rhus extracttreated autologous (E-) cells to test for antigen-specific cytotoxicity.
Target cells (5 X 106) were labeled with "Cr by incubation for 1 h at 37°C in 0.2 ml ofsodium chromate in saline (1 mCi/ml, New England Nuclear, Boston, MA). Targets were then washed and resuspended at 10'/ml in supplemented 10% human AB serum RPMI 1640. A standard 4-h cytotoxicity assay was performed as previously described using V-bottomed wells (17) . Effectors were added at 20, 10, and 5 effector to target cell ratios. Standard deviations were consistently below 10% of the total counts per minute and spontaneous release varied between 15% and 25% of total release. Total release was determined by addition of 1% NP40 detergent in distilled water. Percent cytotoxicity was calculated by the formula: % cytotoxicity = (counts per minute -spontaneous release)/(total release -spontaneous release) X 100.
Antigen-induced lymphokine production. Production of IL-2 and vy-interferon were measured after stimulation with rhus extract. Cultured clone cells were washed extensively and incubated in 10% human AB serum RPMI 1640 supplemented with 4 mM glutamine and gentamycin with a (1:800) dilution of rhus extract. Cells were cultured in flat-bottomed 96-well microtiter trays (Costar, Cambridge, MA) with a final volume of0.2 ml per well, four wells per group at 1 X 10' cultured T cells per well. Autologous (E-) cells irradiated 5000 rad were added at 1 X 104 cells per well as a source of antigen presenting cells. Culture supernatant was harvested daily for 3 d from sets of four wells and pooled for each group. IL-2 content was measured on each day but 'y-interferon content was only measured in day 3 culture supernatant.
IL-2 content was assayed using [3H]thymidine uptake by an IL-2-dependent cell line (CTLL-2). Recombinant IL-2 (Biogen, Cambridge, MA) standards were used to construct a standard curve. The y-interferon concentration was assayed using a solid-phase radioimmunoassay (RIA, Centocor, Malvern, PA) with recombinant y-interferon standards.
PWM-induced IgG production. PBMC (5 X 10' cells/ml) were incubated in RPMI 1640 medium containing 20% FCS, 1% penicillinstreptomycin, 25 The phenotype of RLB9-7 was found to be Tl 1 (99%), T3 (98%), T4 (98%), and T8 (99%) (Figure 1 ). This phenotype was found to be stable over 3 mo. The clone was also positive (89%) for WT3 1, which recognizes the a(3 chain T cell receptor (Fig. 2) .
Urushiol-specific proliferation of RLB9-7. RLB9-7 cells were washed free of IL-2 and added to proliferation assays using irradiated autologous PBMC as antigen-presenting cells. As shown in Table I , RLB9-7 proliferated in response to both rhus extract and pure urushiol. However, no response was seen to tetanus toxoid, although the donor was tetanus toxoid sensitive. DMSO was included as a control for the diluent and irradiated PBMC alone were included as a control for autoreactivity. Neither PBMC or DMSO induced a response significantly different from the media control. 
I
Urushiol in this system acted as an antigen and not as a mitogen. This is supported first by the finding that many clones did not respond to urushiol and also by the inability of PBMC from nonsensitive donors to respond to urushiol (data not shown). This later point has been well established by Byers et al. (3) . The nonmitogeneity of urushiol was important to establish because it has been reported that urushiol can induce murine sponge aggregation in a manner similar to phorbol esters, which are believed to act on the sponge by activation of protein kinase C (20) .
Antigen recognition requirements of RLB9-7 cells. Since RLB9-7 is a T4+T8+ (CD4+CD8+) double-positive cell, it is of interest to determine which surface structures are involved in antigen recognition. For this reason proliferation assays were performed in the presence ofvarious monoclonal antibodies to surface structures known to be relevant to antigen recognition (Table II) . Anti-T3 was able to completely abrogate the proliferation response, as were anti-T8 and anti-HLA-A, B, C. In contrast, anti-T4 had no effect on proliferation. Anti-DR had a mild inhibitory effect which may result from interaction with the RLB9-7 cells which are DR'. In other experiments, anti-T3 (2Ad2A2), anti-HLA-A, B, C (W6/32), and anti-T8 (21Thy2D3) were shown to block both proliferation and cytotoxicity of an alloantigen-specific T8 clone, and anti-T3 (2Ad2A2), anti-DR (949) and anti-T4 (19Thy5D7) and were shown to block both proliferation and cytotoxicity of an alloantigen-specific T4 clone (21) . Thus, despite the presence of the T4 molecule on the cell surface, RLB9-7 behaves as a T8 clone. One may surmise that these cells are class I MHC restricted and use the T8 molecule in cellular interactions. Alternate explanations which will be discussed later include downregulation of cells by anti-T4 or anti-T8.
In order to further establish the antigen recognition requirements of RLB9-7 cells, PBMC from a panel of MHCtyped donors were tested for the ability to present antigen. Several of the donors for this purpose were identified from the records maintained by Dr. Nancy Reinsmoen and Dr. Fritz Bach (University of Minnesota). It was found that antigen-specific proliferation best correlated with shared MHC class I antigens on the antigen-presenting cell (Table III) . Thus, al- though RLB9-7 is CD4+ CD8+, it is MHC restricted to a class I determinant and behaves as a CD8+ cell.
Urushiol-specific suppression of PWM-induced IgG. In order to determine the immunoregulatory effects of RLB9-7, the cells were washed free of IL-2 and added to autologous PBMC in a PWM-induced IgG system. IgG production was then measured by solid-phase RIA. RLB9-7 cells were added to 1 ml of PBMC (5 X 105/ml) in ratios of(1:50), (1:500), and (1:5,000). Cultures were performed in the presence of urushiol or DMSO treated PBMC (Table IV) . It was found that RLB9-7 cells had little effect on IgG production in the absence of antigen. In additional experiments (data not shown), it was found that RLB9-7 cells were unable to provide help for autologous non-T cells for the production of IgG in response to PWM. However, in the presence of urushiol, RLB9-7 cells induced suppression of IgG synthesis in a dose-dependent manner. This suppression was not seen when tetanus toxoid was substituted for urushiol. In additional experiments not shown, rhus extract also induced RLB9-7 cells to suppress IgG production. These data, which are representative of four experiments, indicate that RLB9-7 suppresses PWM-induced IgG production by autologous cells when triggered by urushiol or rhus extract. RLB9-7 cells induced 96% suppressiof at a 1:50 ratio of RLB9-7 cells to PBM and 73% suppression at a 1:500 ratio of RLB9-7 cells to PBM. The ability to suppress at high ratios of RLB9-7 cells to responder cells suggests that suppression was not the result of crowding or media depletion. To further rule out this possibility, RLB9-7 cells were irradiated to prevent proliferation. It was found in three experiments (Table  V) that the irradiation of RLB9-7 cells with 2000 rad did not abrogate suppression even at ratios of (1:50) and (1:500), further substantiating the evidence that RLB9-7-induced suppression does not result from depletion of media or growth factors.
Cytotoxicity ofRLB9-7 cells. Since NK cells are known to nonspecifically suppress many in vitro immune responses (22) , RLB9-7 cells were assayed for the ability to lyse NK-sensitive targets. RLB9-7 cells were tested in a 4-h 51Cr-release cytotoxicity assay against the NK targets K562, Rex, and Molt 4 using effector/target ratios of 20, 10, and 5. In three assays the highest cytotoxicity detected at a (20:1) effector/target ratio was 12% (12%, 6%, 1%). This is negligible compared to the 70-80% cytotoxicity detected in NK-positive T cell lines tested concurrently. These results are also supported by a < 10% expression of the NK cell marker NKH 1 (23) .
RLB9-7 cells were also tested for cytotoxicity against autologous (E-) cells and rhus extract-treated autologous (E-) cells.
In three experiments the levels of cytotoxicity against the rhus (Table III) . For this reason, it was expected that RLB9-7 cells would not suppress IgG production by allogeneic PBMC (Table VI) . The more critical experiment was whether RLB9-7 cells would suppress allogeneic PBM in the presence of autologous antigen-presenting cells (5000 rad irradiated PBMC). It was found in three experiments that, as expected, RLB9-7 did not suppress PBMC from unrelated donors in the presence of urushiol. In addition, this defect was not overcome by the addition of irradiated autologous antigen-presenting cells at a concentration sufficient to induce antigen-specific proliferation. This suggests that suppression may be mediated by direct autologous cellular interaction rather than nonspecific suppressor factors, since the autologous antigen-presenting cells should be sufficient to induce activation and lymphokine production by the RLB9-7 cells.
Antigen-induced lymphokine production by RLB9-7 cells. In order to determine the levels of IL-2 and y-interferon produced by RLB9-7 cells, the cells were washed and cultured in 10% human serum RPMI 1640 as described, in the presence of rhus extract (1:800) and 5000 rad irradiated autologous (E-) antigen-presenting cells. Culture supernatants were harvested from replicate cultures on days 1, 2, and 3 and both IL-2 and 'y-interferon content were measured. It was found that both IL-2 and -y-interferon were produced in small quantities (1.4 U/ml IL-2 maximum at 24 h; 6 U/ml -y-interferon at 72 h).
Control cultures consisting of irradiated antigen-presenting cells plus antigen produced undetectable (< 0.3 U/ml) levels of each lymphokine. By contrast, values reported in the literature for IL-2 and y-interferon producing clones frequently exceed 100 U/ml under similar conditions (4) . In addition, a CD8' urushiol-specific clone (RLA-2) from the same donor which produced 120 U/ml y-interferon in response to rhus extract did not suppress IgG production (data not shown). This suggests that -y-interferon production is not the mediator of antigen-triggered suppression. Conditioned medium from urushiol-stimulated RLB9-7 cells (2 X 106/ml in 20% FCS RPMI 1640) was also added to the PWM assay. However, no suppression was detected.
Effect ofRLB9-7 on tetanus toxoid-specific IgG. The specificity of suppression by RLB9-7 remains to be defined. Since all the preceding experiments used nonspecific PWM-induced IgG synthesis as an assay system, it could be argued that the suppression is nonspecific. However, the possibility remains that PWM stimulates the cells in a manner that mimics antigen-specific stimulation. For this reason, it was decided to investigate the effect of RLB9-7 cells on the induction of tetanus toxoid-specific IgG in vitro. Because the RLB9-7 donor was sensitive to tetanus toxoid and suppression appears to be MHC restricted, autologous PBMC were used. PBMC were cultured 9 d with tetanus toxoid and RT4, an autologous tetanus toxoid-specific CD4' helper clone, as described. Tetanus toxoid-specific IgG was then determined by RIA.
In the absence of tetanus toxoid, a background of 551 cpm was bound. However, the addition of tetanus toxoid boosted cpm bound to 8,474 (Table VII) . RLB9-7 cells did not suppress in the absence of rhus but rather gave a boost in cpm bound. The addition of rhus extract resulted in a decrease of cpm bound from 6,061 to 2,944. Thus, RLB9-7 was able to induce suppression of an unrelated antigen-specific antibody response, indicating that although RLB9-7 triggering is antigen specific, the suppression mechanism is nonspecific.
Discussion
In The suppression mediated by RLB9-7 cells appears to be MHC restricted because RLB9-7 cells were incapable of inhibiting allogeneic PBMC. In contrast, other human suppressor cells have been found to inhibit antibody production by allogeneic PBMC (14) . This lack of inhibition was seen even in the presence of autologous antigen-presenting cells, which should have been sufficent to induce activation of an acute immune response and that such CD4' cells may mediate the delayed hypersensitivity response. This will be the subject of future investigations.
The suppressor T cell "cascade" has been extensively investigated in the murine system by the use of synthetic polymers such as glutamic acid-tyrosine and glutamic acid-alanine-tyrosine (29) as well as the hapten 4-hydroxy-3-nitrophenyl acetyl (30) . It is reported that there are at least three suppressor cells termed TS 1, TS2, and TS3 (31). TS 1 is an Lyt-l-positive Lyt2-negative cell (presumably L3T4+), whereas TS2 and TS3 are Lyt2 positive. TS1 cells produce a suppressor inducer factor (TSFl) which bears I-J determinants and acts in a non-H2-restricted manner to induce TS2 (32) . TS2 cells produce a factor (TSF2) which bears I-J determinants and acts in an H2 (I-J) restricted fashion to induce TS3 (29) , the activity of which is restricted by I-J (31). These factors are genetically restricted by IgH genes (31) as well as being antigen specific. Once TS3 cells are activated, they release TsF3, which after binding antigen on an IJ' factor presenting cell, mediates nonspecific suppression of the contact sensitivity response.
There is also evidence suggesting a three cell suppressor T cell "cascade" in humans. Our laboratory has characterized a CD4+2H4' cell which acts as a suppressor/inducer cell, interacting with CD8' cells to generate suppression (18) . It was found that CD4+2H4' cells activated in the autologous mixed lymphocyte reaction act in an MHC-unrestricted manner to induce CD8-mediated suppression (33) . The 2H4+ antigen appears to be a critical cell interaction molecule in the above system. In other experiments, it was possible to induce CD8+ KLH specific suppressor cells in vitro in the presence of CD4+ cells (34) . These CD8+ cells were able to suppress antigen-specific antibody production in vitro upon transfer to a fresh responder population. It was determined that this radioresistant CD8+ suppressor cell required the presence of "fresh" radiosensitive CD8+ cells in the responder population to effect suppression (35) . It is uncertain how clone RLB9-7 relates to the above data. RLB9-7 is triggered in an antigen-specific manner to effect nonspecific suppression. Furthermore, RLB9-7 cells are capable of inhibiting IgG production by CD4+ cells and non-T cells in the absence of additional CD8+ cells (data not shown), suggesting that RLB9-7 acts as a suppressor effector similar to the TS3 cell in the mouse.
Previous studies have cloned CD4+ antigen specific cells from the peripheral blood and skin lesions ofpatients sensitive to nickel sulfate (4, 6) or cobalt (5) . Many of these clones produced high levels of both IL-2 and y-interferon in response to antigen, suggesting that they are mediators ofdelayed hypersensitivity. There are also reports of cloning CD8+ suppressor cells from skin lesions of patients with lepromatous CD8+ suppressor cells from skin lesions ofpatients with lepromatous (anergic) leprosy (12, 13, 24) and peripheral blood of patients with acute Epstein-Barr virus infection (14) . The lepromintriggered suppressor clones share with RLB9-7 the properties of being triggered specifically by antigen to induce nonspecific suppression. In addition, these clones are radiation resistant and MHC restricted in their triggering. By contrast, the CD8+ suppressor cells cloned from patients with acute E`BV infection were capable of inhibiting antibody production by both PWM-stimulated allogeneic cells and EBV-stimulated autologous cells. These clones were also found to lack NK-and EBV-specific cytotoxicity and appear to be nonantigen specific suppressor cells.
In conclusion, RLB9-7 cells are capable of antigen-dependent, nonspecific suppression of antibody production. Suppression appears to be triggered by recognition of antigen by an a: chain T cell receptor in association with class I MHC. This may represent a mechanism of downregulating delayed hypersensitivity to haptens.
